Alkem Laboratories Limited
ALKEM
Kedudukan dalam Saham
#2812
Alkem Laboratories Ltd. functions as a pharmaceutical enterprise, engaged in... Alkem Laboratories Ltd. functions as a pharmaceutical enterprise, engaged in the research, manufacturing, and worldwide distribution of both medicinal and nutritional products. Its comprehensive offerings encompass a variety of branded and generic drugs, active pharmaceutical ingredients (APIs), biosimilars, and nutraceuticals. These products target both immediate and chronic health issues across numerous therapeutic areas, including anti-infectives, skin conditions, cardiovascular health, respiratory ailments, digestive problems, central nervous system disorders, cancer, urology, and women's health. The company also provides essential vitamins, minerals, and nutritional supplements, in addition to pain relief medications, anti-diabetic treatments, and neurological remedies. Complementing its core pharmaceutical lines, Alkem offers consumer health items such as pregnancy detection kits and condoms. Founded in 1973, the company's headquarters are located in Mumbai, India.
Harga Saham
$55.19
Modal Pasaran
$6.60B
Perubahan (1 hari)
-0.06%
Perubahan (1 tahun)
-12.43%
Negara
IN
Perdagangan Alkem Laboratories Limited (ALKEM)
Kategori
Healthcare
Nisbah P/E bagi Alkem Laboratories Limited (ALKEM)
Nisbah P/E pada October 2026 TTM: 28.72
Menurut laporan kewangan dan harga saham terkini Alkem Laboratories Limited, nisbah P/E semasa (TTM) ialah 28.72. Pada akhir 2024, syarikat mempunyai nisbah P/E sebanyak 33.35.
Sejarah nisbah P/E bagi Alkem Laboratories Limited dari 2010 hingga 2026
Nisbah P/E pada akhir setiap tahun
| Tahun | Nisbah P/E | Ubah |
|---|---|---|
| 2026 (TTM) | 28.72 | 7.58% |
| 2025 | 26.70 | -19.94% |
| 2024 | 33.35 | -19.17% |
| 2023 | 41.26 | 56.84% |
| 2022 | 26.31 | 25.91% |
| 2021 | 20.89 | -15.32% |
| 2020 | 24.67 | -10.19% |
| 2019 | 27.47 | -24.47% |
| 2018 | 36.37 | 23.08% |
| 2017 | 29.55 | 35.14% |
| 2016 | 21.87 | -48.16% |
| 2015 | 42.19 | 12.11% |
| 2014 | 37.63 | 13.01% |
| 2013 | 33.30 | -14.24% |
| 2012 | 38.83 | -23.99% |
| 2011 | 51.08 | -27.33% |
| 2010 | 70.29 | 0.00% |
Nisbah P/E untuk syarikat serupa atau pesaing
| Syarikat | Nisbah P/E | Perbezaan Nisbah P/E | Negara |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 34.96 | 21.71% |
IN
|
Cara membaca nisbah P/E
Nisbah Harga/Perolehan (P/E) mengukur hubungan antara harga saham syarikat dan pendapatan sesaham.
P/E yang rendah tetapi positif menunjukkan syarikat menjana keuntungan tinggi berbanding dengan penilaian semasa dan mungkin dinilai rendah. P/E negatif yang tinggi (hampir 0) menunjukkan kerugian besar.
Syarikat dengan P/E melebihi 30 atau negatif biasanya dilihat sebagai "saham pertumbuhan", bermaksud pelabur menjangkakan pertumbuhan atau keuntungan masa depan.
Syarikat dengan P/E positif di bawah 10 biasanya dianggap sebagai "saham nilai", bermaksud syarikat sudah menguntungkan dan tidak dijangka berkembang pesat.